synthesis of prodrug analogs and cyclopentane peptide nucleic acid (PNA) precursors
Overview
- Response deadline
- 9:00 AM EDT
- Posted
- July 16, 2026
- Notice type
- Presolicitation
- Set-aside
- No Set aside used
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH OLAO
- Place of performance
- Bethesda, Maryland, 20892
- Last updated
- Oct 28, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 75N98026Q00819CREAGENINC
- Notice ID
- f91c144744ce480287dce66492d1ddf8
Description
Background Information: The National Institute of Diabetes and Digestive and Kidney Diseases conducts and supports biomedical research to improve the understanding, prevention, and treatment of diseases affecting human health.
Within the Laboratory of Bioorganic Chemistry, the Synthetic Bioactive Molecules Section conducts research focused on the discovery and development of novel therapeutic compounds for the treatment and prevention of cancer and HIV infection. Ongoing studies have identified several promising sulfanylbenzamide-derived compounds and cyclopentane peptide nucleic acid precursor materials with potential applications as anti-cancer therapeutics, HIV prevention and treatment agents, and diagnostic technologies.
To support these research efforts, the Synthetic Bioactive Molecules Section requires synthesis scale-up, custom synthesis, purification, and characterization of optimized lead compounds and specialized precursor materials. These materials are not commercially available and require specialized synthetic expertise and production capabilities to generate quantities sufficient for continued preclinical evaluation.
The materials produced under this requirement will be used in ongoing preclinical studies to evaluate compound activity, optimize lead candidates, and support advancement toward future clinical development.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Documents
Files (1)
- Download
Notice of Intent - VISHNU CREAGEN INC.docx
75 KBAdded in Presolicitation version 3Posted
Lifecycle
- 3Version 3PresolicitationArchivedCurrent
synthesis of prodrug analogs and cyclopentane peptide nucleic acid (PNA) precursors
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N98026Q00819CREAGENINC
Archive Date
Jul 26, 2026
Office Address
BETHESDA, MD, 20892